EMA’s painful departure

Financial Times

5 October 2017 - EU is acting rapidly and decisively on the future of the flagship agency.

There are only two certainties for the future of the EMA: that it will move out of London after Brexit, and that the UK will have no voice in deciding where it goes. Everything else is open to question — and is causing growing concern.

As the countdown towards March 2019 advances, the UK continues to send mixed messages about what relationship it wants with the EU and the timetable for implementation. But Brussels is acting rapidly and decisively on the future of the flagship agency soon to be stranded outside its borders.

Read Financial Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , Regulation